Albaad Massuot Yitzhak Ltd.

Albaad Massuot Yitzhak Ltd.

TTASE:ALBA
3,013.00
ILA
0.00
(0.00%)
407.90EPS
7.83P/E
57.38BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
107.99
99.99
114.19
115.47
111.19
106.97
101.17
92.21
89.45
93.42
91.73
92.23
94.48
92.8
Basic EPS, GAAP
1.22
4.64
3.08
4.17
2.58
-2.52
-5.28
6.55
-1.38
-9.28
1.62
2.41
3.74
3.93
Free Cash Flow per Basic Share
3.31
-0.94
-3.51
-1.76
-1.84
-1.57
4.38
7.39
-2.46
-4.34
6.49
5.45
3.02
4.75
Dividend per Share
1.15
1.04
1.38
1.53
1.53
- -
- -
1.62
- -
- -
- -
- -
- -
- -
Book Value per Share
31
35.52
36.27
38.35
38.66
37.08
30.45
36.59
32.89
18.6
21.13
22.88
25.43
25.95
Tangible Book Value per Share
17.07
22.17
23.44
26.3
27.27
28.97
24.85
33.15
24.78
14.26
16.9
19.19
21.91
22.86
Basic Weighted Avg Shares
13
14
13
13
13
13
13
15
15
16
19
19
19
19
Sales/Revenue/Turnover
1,413
1,445
1,494
1,510
1,455
1,399
1,323
1,425
1,383
1,454
1,710
1,720
1,762
1,730
Operating Margin (%)
6.3
5.76
4.96
6.11
4.92
3.97
5.16
14.27
8.12
0.82
5.53
6.49
6.65
6.96
Depreciation Expense
59
61
62
61
63
68
84
78
81
93
94
94
98
93
Net Income, GAAP
16
67
40
55
34
-33
-69
101
-21
-144
30
45
70
73
Effective Tax Rate (%)
56.26
18.59
30.27
25.28
30.16
- -
87.73
25.69
30.61
- -
25.06
32.38
25.43
22.62
Profit Margin (%)
1.13
4.64
2.69
3.61
2.32
-2.35
-5.22
7.11
-1.54
-9.94
1.77
2.61
3.96
4.23
Working Capital
148
169
132
102
150
167
120
149
194
-198
-119
-60
-32
-16
LT Debt
335
338
368
368
406
421
432
418
562
269
405
391
362
335
Total Equity
407
465
475
502
507
487
405
486
437
355
403
437
487
497
Return on Invested Capital (%)
- -
7.93
5.16
6.49
4.44
- -
0.5
12.25
6.58
- -
5.85
6.27
7.39
7.96
Return on Capital (%)
- -
8.91
5.12
6.11
4.09
- -
-6.63
10.58
-0.64
- -
4.54
5.79
7.66
8.04
Return on Common Equity (%)
- -
15.4
8.57
11.18
6.7
-6.65
-15.65
23.11
-4.7
-37.19
8.16
10.94
15.47
15.35

Capital Structure

ILS

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
340
303
280
LT Borrowings
143
141
136
LT Finance Leases
220
207
199
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
19
19
19
Market Capitalization
671
565
574

Working Capital

ILS

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
594
595
585
Cash, Cash Equivalents & STI
11
10
22
Accounts Receivable, Net
207
204
202
Inventories
331
332
317
Total Current Liabilities
626
624
601
Payables & Accruals
- -
- -
- -
ST Debt
340
303
280
Deferred Revenue
- -
- -
- -

Growth Rates

ILS

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
1.05%
0.92%
11.29%
Free Cash Flow
-73.51%
-79.09%
-44.55%
Net Income, GAAP
10.19%
87.71%
55.27%
Sales/Revenue/Turnover
1.87%
4.56%
2.44%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

ILS

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
416
440
451
412
1,720
2025
422
462
460
417
1,762
2026
426
427
- -
- -
- -

Quarterly Earnings Per Share

ILS

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.76
0.78
0.65
0.22
2.41
2025
0.59
1.29
0.92
0.94
3.74
2026
1.01
1.06
- -
- -
- -

Quarterly Dividends Per Share

ILS

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Jacob Heen
Full Time Employees
2,073
Sector
Consumer non-durables
Industry
Household/Personal care
Address
MP Sde Gat Masu'ot Itzhak Israel 7985800
IPO Date
Jan 1, 1994
Website
albaad.com
Business
Albaad Massuot Yitzhak Ltd is a global manufacturer and supplier of wet wipes and feminine hygiene products, headquartered in Nir Yitzhak, Israel, and founded in 1985. The company offers a diversified portfolio including baby and toddler wipes; facial and cosmetic wipes such as refreshing cosmetic, exfoliating, and make-up remover wipes; household cleaning wipes; flushable moist toilet paper; and feminine hygiene products including tampons. It also produces professional wipes for para-medical, veterinary, automotive, and restaurant uses; adult care wipes including adult bed and bath; personal care wipes including intimate wipes; para-pharma wipes; and sachets. Albaad provides contract manufacturing, private label, and institutional manufacturing services, servicing global markets with an emphasis on high quality, cost-effective, and sustainable products facilitated by in-house production of nonwoven materials and advanced automated machinery. In the last 1-2 years, Albaad has focused on maintaining supply chain efficiencies through in-house logistics centers, ensuring resilience against raw material disruptions and scaling operations to meet growing market demands globally. The company has integrated sustainability into its product lines, notably by offering flushable, biodegradable wipes and enhancing its production processes to reduce carbon footprint. Leadership changes include the appointment of Jacob Heen as CEO in late 2022 and Gal Grafi as CFO in early 2023. Albaad continues expanding its presence particularly in the European market, where it generates significant revenue, supported by strategic operational improvements and product innovations. Albaad operates primarily in the consumer staples sector within the household and personal products industry, employing approximately 1,670 staff. Its operational footprint spans Europe, Israel, and other international markets, with Germany representing a key revenue market. The company emphasizes collaboration with top retailers, drug stores, and global brands to develop premium wet wipes and feminine hygiene offerings. Recent financial performance reflects steady revenue growth and continued commitment to dividends, supporting its position as a leading worldwide manufacturer in its segment.